Jorge Conde

Jorge Conde is a General Partner on the Bio + Health team at Andreessen Horowitz (a16z), where he invests at the intersection of biology, computer science, and engineering. Born in Miami to Cuban and Peruvian parents, Conde co-founded Knome — the first company to offer whole-genome sequencing directly to consumers — alongside Harvard geneticist George Church, then spent years as CSO, CFO, and CPO at Syros Pharmaceuticals before joining a16z in 2017. An MIT Technology Review Innovator Under 35 and Henry Crown Fellow at the Aspen Institute, he is one of the most prominent voices arguing that the 21st century belongs to biology the way the 20th belonged to physics.